alpha-D-Galp-(1->6)-[alpha-D-Glcp-(1->4)]-D-Glcp

Term ID

CHEBI:148779

Synonyms

(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[[(2R,3S,4R,5R)-4,5,6-trihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol
alpha-D-galactopyranosyl-(1->6)-[alpha-D-glucopyranosyl-(1->4)]-D-glucopyranose
alpha-D-gluco-hexopyranosyl-(1->4)-[alpha-D-galacto-hexopyranosyl-(1->6)]-D-gluco-hexopyranose
Glc(a1-4)[Gal(a1-6)]Glc

Definition

A trisaccharide that is D-glucopyranose in which the hydroxy groups at positions 4 and 6 have been converted into the corresponding α-D-glucopyranosyl and α-D-galactopyransoyl derivatives, respectively.

References

glygen:G29777ZC
glytoucan:G29777ZC
kegg.glycan:G09701

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-Galp-(1->6)-[alpha-D-Glcp-(1->4)]-D-Glcp

Phenotype where environments contain alpha-D-Galp-(1->6)-[alpha-D-Glcp-(1->4)]-D-Glcp

Phenotype modified by environments containing alpha-D-Galp-(1->6)-[alpha-D-Glcp-(1->4)]-D-Glcp

Phenotype affecting alpha-D-Galp-(1->6)-[alpha-D-Glcp-(1->4)]-D-Glcp

Human Disease Model